A Text Messaging-Based Smoking Cessation Program for Adult Smokers: Randomized Controlled Trial

Por Ybarra, Michele, Bağcı Bosi, A Tülay, Korchmaros, Josephine, Emri, Salih
Publicado em 2012

Correction: A Text Messaging-Based Smoking Cessation Program for Adult Smokers: Randomized Controlled Trial

Por Ybarra, Michele, Bağci Bosi, A Tülay, Korchmaros, Josephine, Emri, Salih
Publicado no J Med Internet Res (2015)

Design Considerations in Developing a Text Messaging Program Aimed at Smoking Cessation

Por Ybarra, Michele L, Holtrop, Jodi Summers, Bağci Bosi, A Tülay, Emri, Salih
Publicado em 2012

Combined surgery and chemotherapy for the treatment of primary gastrointestinal intermediate- or high-grade non-Hodgkin's lymphomas.

Por Bellesi, G., Alterini, R., Messori, A., Bosi, A., Bernardi, F., di Lollo, S., Ferrini, P. R.
Publicado em 1989

Interest in technology-based and traditional smoking cessation programs among adult smokers in Ankara, Turkey

Por Ybarra, Michele L, Bağci Bosi, A Tülay, Bilir, Nazmi, Holtrop, Jodi S, Korchmaros, Josephine, Emri, Salih
Publicado em 2011

Proposed definition of ‘poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo

Por Olivieri, A, Marchetti, M, Lemoli, R, Tarella, C, Iacone, A, Lanza, F, Rambaldi, A, Bosi, A
Publicado em 2012

Role of critical care outreach to provide the intention to treat of hematological disorders: a pilot study

Por Guerri, I, Greco, C, Perretta, L, Cianfaldoni, G, Longo, G, Batacchi, S, Spina, R, Bosi, A, Zagli, G, Peris, A
Publicado em 2010

Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value

Por Vannucchi, A M, Rotunno, G, Bartalucci, N, Raugei, G, Carrai, V, Balliu, M, Mannarelli, C, Pacilli, A, Calabresi, L, Fjerza, R, Pieri, L, Bosi, A, Manfredini, R, Guglielmelli, P
Publicado em 2014

Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine

Por Valencia, A, Masala, E, Rossi, A, Martino, A, Sanna, A, Buchi, F, Canzian, F, Cilloni, D, Gaidano, V, Voso, M T, Kosmider, O, Fontenay, M, Gozzini, A, Bosi, A, Santini, V
Publicado em 2014

Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patients

Por Rambaldi, A, Bacigalupo, A, Fanin, R, Ciceri, F, Bonifazi, F, Falda, M, Lambertenghi-Deliliers, G, Benedetti, F, Bruno, B, Corradini, P, Alessandrino, P E, Iacopino, P, Arcese, W, Scimè, R, Raimondi, R, Sica, S, Castagna, L, Lamparelli, T, Oneto, R, Lombardini, L, Pollichieni, S, Algarotti, A, Carobbio, A, Sacchi, N, Bosi, A
Publicado em 2012

The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospectiv...

Por Todisco, E, Ciceri, F, Oldani, E, Boschini, C, Micò, C, VanLint, M T, Donnini, I, Patriarca, F, Alessandrino, P E, Bonifazi, F, Arcese, W, Barberi, W, Marenco, P, Terruzzi, E, Cortelazzo, S, Santarone, S, Proia, A, Corradini, P, Tagliaferri, E, Falcioni, S, Irrera, G, Dallanegra, L, Castagna, L, Santoro, A, Camboni, A, Sacchi, N, Bosi, A, Bacigalupo, A, Rambaldi, A
Publicado em 2013